Clinical Presentation & Symptoms

How Does TMD Present?

The most common presenting symptom of temporomandibular disorder (TMD) is pain. This is often felt as a dull, persistent ache around the jaw, temple, cheek, ear, or side of the face. The pain may fluctuate during the day and can become sharper during chewing, talking, yawning, clenching, or wide mouth opening.

TMD pain may be localised to the temporomandibular joint itself, but it can also radiate to the ear, temple, periorbital region, angle of the mandible, posterior neck, and upper shoulder region. This overlapping referral pattern is one reason why TMD may be mistaken for dental pain, migraine, sinus disease, ear pathology, or cervical spine-related pain.

Symptoms may be intermittent or persistent. Some patients have pain-free intervals, while others develop chronic symptoms with sleep disturbance, anxiety, reduced jaw function, food avoidance, and impaired quality of life.

Common Symptoms

Myogenous vs Arthrogenous TMD

A key clinical step is deciding whether the dominant pain source is muscular, joint-related, or mixed. This distinction guides treatment. Myogenous TMD tends to respond best to self-management, physiotherapy, behavioural strategies, medication, dry needling, trigger point therapy, or botulinum toxin in selected refractory cases. Arthrogenous TMD may require joint-focused treatment such as splints, anti-inflammatory therapy, hyaluronic acid, platelet-rich plasma, prolotherapy, or arthrocentesis.

Clinical Presentation by TMD Subtype

Physical Examination

A careful clinical examination is usually sufficient to determine whether TMJ pain is arising predominantly from the jaw muscles, the joint itself, or both. In most patients, a focused 5–10 minute examination provides all the information needed to guide treatment.

Brief Diagnostic Criteria (DC)/TMD Examination Protocol

The internationally validated DC/TMD examination can be simplified into a very practical screening assessment. Palpating just three key areas on both sides provides excellent diagnostic accuracy for identifying painful TMD.

Range of Motion Assessment

Mouth opening is assessed by measuring the distance between the upper and lower front teeth. Normal opening is usually between 35 and 55 mm (roughly the width of three fingers).

Examining the Medial and Lateral Pterygoid Muscles

The pterygoid muscles are deep muscles that help move the jaw. They are commonly involved in difficult or persistent TMD.

Functional Orthopaedic Tests

Differentiating Myogenous vs Arthrogenous TMD

In practice, the diagnosis usually becomes clear by combining the patient’s history with three key findings: where the pain is located, what structures are tender on examination, and how the jaw moves.

Diagnostic Criteria & Imaging

Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)

The Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) is the internationally accepted system used to diagnose TMJ disorders. In practice, it provides a structured way to determine whether symptoms are arising from the jaw muscles, the joint itself, or both.

Although the formal system is highly detailed, most clinicians can reach an accurate diagnosis using a focused history, a brief physical examination, and imaging only when clinically necessary.

The Dual-Axis Framework

The DC/TMD considers two equally important aspects of the condition.

A Simple Tiered Approach to Diagnosis

In everyday clinical practice, diagnosis can be approached in three simple steps.

The 5Ts Screening Questionnaire

A simple screening tool can quickly identify patients who may have TMD.

A positive response to several of these questions suggests that a focused TMJ examination is warranted.

When to Use MRI and CBCT

Imaging is not routinely required. Most patients can be diagnosed and treated successfully based on clinical assessment alone.

Conservative & Pharmacological Management

Most patients with temporomandibular disorder (TMD) improve without surgery. The best outcomes are achieved when treatment is tailored to the underlying pain source and progresses in a stepwise manner, beginning with simple measures and escalating only when necessary.

Treatment Principles

Treatment should address both the physical and behavioural factors driving pain. Patients often improve substantially when they understand the condition, reduce aggravating habits, improve sleep, and follow a structured rehabilitation plan.

Self-Management Strategies

Physical Therapy Modalities

Physical therapy is one of the most effective treatments for TMD. The most useful approaches are jaw exercises, posture correction, manual therapy, and trigger point treatment. Modalities such as TENS or low-level laser therapy may provide additional short-term relief but are generally considered supportive rather than essential.

Jaw Exercises and Manual Therapy

Pharmacological Management

Medication is used to reduce pain, improve sleep, and support rehabilitation. It is most effective when combined with physical therapy and self-management.

Occlusal Splints and Orthotics

Stabilisation splints (often called night guards) reduce muscle activity and protect the teeth in patients with clenching or grinding. They are most effective when used alongside jaw exercises and behavioural modification rather than as a stand-alone treatment.

Injection Therapies for TMJ Pain

Injection therapies are an important part of temporomandibular disorder (TMD) management when symptoms persist despite appropriate self-management, physiotherapy, medication, and splint therapy. They are not usually first-line treatments, but they can be very helpful when the pain source has been carefully identified.

The choice of injection depends on whether the main problem is myogenous — arising from the jaw muscles — or arthrogenous — arising from the joint itself. Muscle-related TMD may respond to botulinum toxin, trigger point treatment, or selected novel intramuscular injections. Joint-related TMD may respond to arthrocentesis, hyaluronic acid, platelet-rich plasma, corticosteroid injection, or dextrose prolotherapy.

Comparison of Injectable Therapies

General Intra-Articular Injection Technique

Intra-articular TMJ injections aim to place medication accurately into the joint space. Traditional landmark-guided techniques use the point approximately 10 mm anterior and 2 mm inferior to the tragus along the tragus-to-lateral-canthus line. However, the TMJ is small, anatomically variable, and difficult to access reliably using landmarks alone.

Ultrasound guidance allows the clinician to visualise the mandibular condyle, joint space, needle pathway, and surrounding soft tissues in real time. This is particularly important when treating the lower joint space, pterygoid muscles, or patients with altered anatomy, restricted opening, or previous surgery.

Arthrocentesis Technique

Arthrocentesis means washing out the TMJ with sterile fluid. It can reduce pain by removing inflammatory chemicals, releasing adhesions, improving joint lubrication, and helping the disc move more freely. It is particularly useful for painful joint locking, restricted mouth opening, disc displacement, and osteoarthritis-related joint pain.

Corticosteroid Injections

Corticosteroids are powerful anti-inflammatory medicines. They can be useful when there is a clear inflammatory joint flare, synovitis, acute arthralgia, or painful osteoarthritis flare. Their main advantage is rapid symptom relief.

Steroid injections are best used selectively rather than repeatedly. They are not the preferred long-term strategy for chronic TMJ osteoarthritis, especially when repeated treatment cycles are likely to be needed.

Hyaluronic Acid (HA) Viscosupplementation

Hyaluronic acid is a naturally occurring substance found in joint fluid. In arthritis and chronic joint inflammation, the quality of the joint fluid deteriorates. HA injections aim to restore lubrication, improve shock absorption, reduce inflammation, and support smoother joint movement.

HA is one of the safest and most commonly used intra-articular TMJ treatments. It is particularly useful for TMJ osteoarthritis, disc-related pain, hypomobility, and chronic arthrogenous TMD.

Different HA products vary in molecular weight and formulation, but human TMJ studies have not consistently shown one formulation to be clearly superior. In practice, selection depends on availability, cost, joint condition, and clinician experience.

Platelet-Rich Plasma (PRP)

Platelet-rich plasma is prepared from the patient’s own blood. The sample is processed to concentrate platelets, which contain growth factors involved in tissue repair, inflammation control, and healing. PRP is used in TMJ osteoarthritis, internal derangement, and persistent arthrogenous pain where a regenerative approach is appropriate.

PRP is usually injected into the superior joint space, often after arthrocentesis in more advanced or restricted cases. It is particularly attractive because it is autologous, meaning it comes from the patient’s own body, with no allergy risk and no known cartilage toxicity.

Dextrose Prolotherapy

Dextrose prolotherapy involves injecting a dextrose solution into or around the TMJ to stimulate a controlled healing response. It is particularly useful when the problem is not simply inflammation, but joint laxity, hypermobility, recurrent subluxation, or chronic mechanical dysfunction.

Higher-concentration dextrose solutions aim to strengthen supporting ligaments and periarticular tissues. Lower concentrations may have more of a pain-modulating effect. The best-studied TMJ protocol uses 20% dextrose with local anaesthetic.

Botulinum Toxin A for Myogenous TMD

Botulinum toxin A is used for muscle-related TMD, particularly severe bruxism, masseter hypertrophy, refractory myofascial pain, and selected pterygoid muscle problems. It works by reducing excessive muscle contraction and may also reduce pain signalling from sensitised nerve endings.

It is most appropriate when conservative treatment has failed and the examination clearly shows a dominant muscular pain driver. It should not be used as a cosmetic-style masseter reduction treatment in patients whose main problem is joint pathology.

The usual effect begins within 3–7 days, peaks at 2–4 weeks, and lasts around 3–6 months. Response should be reviewed before repeating treatment, and if there is no meaningful benefit after two well-targeted cycles, the diagnosis should be reconsidered.

Pterygoid Muscle Injections

The medial and lateral pterygoid muscles are deep jaw muscles that can contribute to complex TMD presentations. They are not routine injection targets and should only be treated when the history and examination clearly suggest their involvement.

Granisetron Intramuscular Injection

Granisetron is a 5-HT3 receptor antagonist more commonly known as an anti-sickness medication, but it has also been studied as an intramuscular treatment for refractory myofascial TMD. Its proposed benefit is pain modulation rather than muscle weakening.

It may be considered in selected patients with persistent muscle-related TMD where conventional treatment has failed, particularly when botulinum toxin is not suitable or when avoiding muscle weakening is preferred. The evidence base is still much smaller than for established options such as HA, PRP, prolotherapy, or Botox.

Novel and Emerging Treatments

Several newer biological approaches are being studied for TMJ pain. These remain emerging treatments and should be discussed carefully with patients, including the limitations of the evidence.

Pain Spa Expert Perspective

Pterygoid Muscle Injections

Injection of the medial and lateral pterygoid muscles is one of the most technically demanding aspects of TMJ treatment. These muscles lie deep within the infratemporal fossa and are surrounded by important blood vessels and nerves. For this reason, they should only be performed by experienced clinicians using real-time ultrasound or EMG guidance whenever possible.

Pterygoid injections are reserved for carefully selected patients with persistent symptoms that have not responded to conservative treatment, splints, and treatment of the more superficial jaw muscles. :contentReference[oaicite:0]{index=0}

When Are Pterygoid Injections Helpful?

Medial Pterygoid Injection

The medial pterygoid is a powerful jaw-closing muscle located on the inner surface of the mandibular ramus. It is commonly involved in deep jaw pain that may not respond to standard masseter and temporalis treatment.

In a large published series including 1,068 botulinum toxin injections, treatment of the medial pterygoid was associated with excellent outcomes and no significant adverse effects. :contentReference[oaicite:1]{index=1}

Lateral Pterygoid Injection

The lateral pterygoid plays a key role in jaw opening, protrusion, and disc control. Overactivity of this muscle can contribute to painful clicking, disc displacement, and recurrent jaw dislocation.

Clinical studies have shown that targeted injection into the lateral pterygoid can reduce clicking and improve disc position in appropriately selected patients. :contentReference[oaicite:2]{index=2}

Indications, Dosing, and Safety Summary

Role of Ultrasound Guidance

Ultrasound guidance allows the clinician to see the temporomandibular joint, surrounding muscles, blood vessels, and the needle in real time during the procedure. This makes injections more accurate and improves safety, especially when treating small joints or deep muscles such as the pterygoids.

In published studies, ultrasound guidance has increased injection accuracy from approximately 55% with blind landmark techniques to around 95%. This is particularly important when injecting the lower joint space or deep masticatory muscles. :contentReference[oaicite:0]{index=0}

Why Ultrasound Guidance Matters

Ultrasound Scanning Technique

A small high-frequency probe is placed over the jaw joint while the patient lies semi-reclined. The clinician identifies the mandibular condyle and joint space, then guides the needle under direct vision to the target area.

When Ultrasound Guidance Is Strongly Recommended

Advantages and Limitations

Expert TMJ Care at Pain Spa

Temporomandibular disorders can be surprisingly complex. Some patients have predominantly muscle-related pain, others have joint inflammation, disc displacement, osteoarthritis, hypermobility, or a combination of several overlapping problems. Successful treatment depends on identifying the dominant pain generator and selecting the most appropriate therapy.

Dr Krishna is a specialist interventional pain physician with extensive experience in ultrasound-guided pain procedures. His approach combines a detailed assessment, precise diagnosis, conservative treatment, and image-guided interventions when appropriate.

Dr Krishna’s Approach to TMJ Disorders

Areas of Expertise

Ultrasound-Guided TMJ Procedures Available at Pain Spa

Treatment Escalation and When to Refer

Most temporomandibular disorders improve with simple measures such as education, jaw exercises, stress reduction, medication, and splint therapy. If symptoms persist, treatment is escalated in a logical stepwise manner based on whether the pain is mainly muscular (myogenous) or joint-related (arthrogenous).

Surgery is rarely required. Most patients improve with conservative care and, when appropriate, carefully targeted ultrasound-guided injections.

Stepwise Escalation for Myogenous TMD

Stepwise Escalation for Arthrogenous TMD

When to Refer to Specialists

Surgical Options

Surgery is reserved for a small minority of patients with severe structural joint problems or persistent symptoms despite appropriate non-surgical treatment.

Frequently Asked Questions

Temporomandibular disorders are common and often cause understandable concern. Below are answers to some of the questions patients ask most frequently during consultations.

Key Clinical Take-Home Messages

Temporomandibular disorders are common, treatable, and usually improve with a structured approach that combines accurate diagnosis, conservative treatment, and targeted interventions when necessary.

References